Peroxiredoxin 5 Antibody (3E6) Summary
PRDX5 (NP_036226, 105 a.a. ~ 215 a.a) partial recombinant protein with GST tag.LPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL
PRDX5 (3E6)
IgG2a Kappa
Monoclonal
Mouse
PRDX5
IgG purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- ELISA
Antibody reactive against recombinant protein on ELISA. GST alone used as a negative control.
Reactivity Notes
Human. Other species not tested.
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
PBS (pH 7.4)
No Preservative
IgG purified
Notes
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for Peroxiredoxin 5 Antibody (3E6)
- ACR1
- ACR1Peroxisomal antioxidant enzyme
- Alu corepressor 1
- Alu co-repressor 1
- Antioxidant enzyme B166
- AOEB166
- AOEB166Peroxiredoxin V
- AOPP
- B166
- EC 1.11.1.15
- Liver tissue 2D-page spot 71B
- MGC117264
- MGC142283
- MGC142285
- Peroxiredoxin 5
- peroxiredoxin-5, mitochondrial
- PLPThioredoxin peroxidase PMP20
- PMP20
- PRDX5
- PRDX6
- PRXV
- prx-V
- SBBI10
- Thioredoxin reductase
- TPx type VI
Background
This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in different tissues under normal conditions and during inflammatory processes. This protein interacts with peroxisome receptor 1. The crystal structure of this protein in its reduced form has been resolved to 1.5 angstrom resolution. This gene uses alternate in-frame translation initiation sites to generate mitochondrial or peroxisomal/cytoplasmic forms. Three transcript variants encoding distinct isoforms have been identified for this gene.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets :　URAT2 inhibitors